カテゴリ： 世界, 医療/バイオ, QYResearch

クロストリジウムディフィシルイムノアッセイの世界市場2023年：共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)

■ 英語タイトル：Global Clostridium Difficile Immunoassays Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7444）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7444
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[クロストリジウムディフィシルイムノアッセイの世界市場2023年：共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はクロストリジウムディフィシルイムノアッセイのグローバル市場について調査・分析し、世界のクロストリジウムディフィシルイムノアッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Hologic Inc.、TECHLAB, Inc.、Roche AG、Merck & Co.、Pfizer, Inc.、Actelion Pharmaceuticals、Thermo Fisher Scientific Inc.、Alere, Inc.、Trinity Biotech、Baxter International Inc.、Sanofi SA、Summit Therapeutics、AstraZeneca Plc.、Novartis AGなどが含まれています。クロストリジウムディフィシルイムノアッセイのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、クロストリジウムディフィシルイムノアッセイ市場規模を算出する際に考慮しました。

・クロストリジウムディフィシルイムノアッセイ市場の概要
- クロストリジウムディフィシルイムノアッセイの種類別セグメント
- 世界のクロストリジウムディフィシルイムノアッセイ市場規模：タイプ別分析（共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)）
- クロストリジウムディフィシルイムノアッセイの用途別セグメント
- 世界のクロストリジウムディフィシルイムノアッセイ市場規模：用途別分析（病院、診療所、その他）
- 世界のクロストリジウムディフィシルイムノアッセイ市場規模予測（2018年-2029年）

・クロストリジウムディフィシルイムノアッセイ市場の成長トレンド
- クロストリジウムディフィシルイムノアッセイの地域別市場規模（2018年-2029年）
- クロストリジウムディフィシルイムノアッセイ市場ダイナミクス
- クロストリジウムディフィシルイムノアッセイの業界動向
- クロストリジウムディフィシルイムノアッセイ市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)
- 世界のクロストリジウムディフィシルイムノアッセイのタイプ別市場規模（2018年-2023年）
- 世界のクロストリジウムディフィシルイムノアッセイのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界のクロストリジウムディフィシルイムノアッセイの用途別市場規模（2018年-2023年）
- 世界のクロストリジウムディフィシルイムノアッセイの用途別市場規模（2024年-2029年）

・クロストリジウムディフィシルイムノアッセイの地域別市場規模
- 北米のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 米国のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- ヨーロッパのクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- アジア太平洋のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 中国のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 日本のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 韓国のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- インドのクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- オーストラリアのクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 中南米のクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）
- 中東・アフリカのクロストリジウムディフィシルイムノアッセイ市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Hologic Inc.、TECHLAB, Inc.、Roche AG、Merck & Co.、Pfizer, Inc.、Actelion Pharmaceuticals、Thermo Fisher Scientific Inc.、Alere, Inc.、Trinity Biotech、Baxter International Inc.、Sanofi SA、Summit Therapeutics、AstraZeneca Plc.、Novartis AG

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Clostridium Difficile Immunoassays market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Clostridium Difficile Immunoassays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Clostridium Difficile Immunoassays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Clostridium Difficile Immunoassays in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Clostridium Difficile Immunoassays include Hologic Inc., TECHLAB, Inc., Roche AG, Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Thermo Fisher Scientific Inc., Alere, Inc. and Trinity Biotech, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clostridium Difficile Immunoassays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clostridium Difficile Immunoassays.
The Clostridium Difficile Immunoassays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clostridium Difficile Immunoassays market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clostridium Difficile Immunoassays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Hologic Inc.
TECHLAB, Inc.
Roche AG
Merck & Co.
Pfizer, Inc.
Actelion Pharmaceuticals
Thermo Fisher Scientific Inc.
Alere, Inc.
Trinity Biotech
Baxter International Inc.
Sanofi SA
Summit Therapeutics
AstraZeneca Plc.
Novartis AG
Segment by Type
Common antigen (common enzyme or GDH) Test
Toxigenic Anaerobic Culture Test
Tissue Cytotoxin Neutralization Assay
Toxins A and B (EIA)
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clostridium Difficile Immunoassays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clostridium Difficile Immunoassays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Common antigen (common enzyme or GDH) Test
1.2.3 Toxigenic Anaerobic Culture Test
1.2.4 Tissue Cytotoxin Neutralization Assay
1.2.5 Toxins A and B (EIA)
1.3 Market by Application
1.3.1 Global Clostridium Difficile Immunoassays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clostridium Difficile Immunoassays Market Perspective (2018-2029)
2.2 Clostridium Difficile Immunoassays Growth Trends by Region
2.2.1 Global Clostridium Difficile Immunoassays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clostridium Difficile Immunoassays Historic Market Size by Region (2018-2023)
2.2.3 Clostridium Difficile Immunoassays Forecasted Market Size by Region (2024-2029)
2.3 Clostridium Difficile Immunoassays Market Dynamics
2.3.1 Clostridium Difficile Immunoassays Industry Trends
2.3.2 Clostridium Difficile Immunoassays Market Drivers
2.3.3 Clostridium Difficile Immunoassays Market Challenges
2.3.4 Clostridium Difficile Immunoassays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clostridium Difficile Immunoassays Players by Revenue
3.1.1 Global Top Clostridium Difficile Immunoassays Players by Revenue (2018-2023)
3.1.2 Global Clostridium Difficile Immunoassays Revenue Market Share by Players (2018-2023)
3.2 Global Clostridium Difficile Immunoassays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clostridium Difficile Immunoassays Revenue
3.4 Global Clostridium Difficile Immunoassays Market Concentration Ratio
3.4.1 Global Clostridium Difficile Immunoassays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clostridium Difficile Immunoassays Revenue in 2022
3.5 Clostridium Difficile Immunoassays Key Players Head office and Area Served
3.6 Key Players Clostridium Difficile Immunoassays Product Solution and Service
3.7 Date of Enter into Clostridium Difficile Immunoassays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clostridium Difficile Immunoassays Breakdown Data by Type
4.1 Global Clostridium Difficile Immunoassays Historic Market Size by Type (2018-2023)
4.2 Global Clostridium Difficile Immunoassays Forecasted Market Size by Type (2024-2029)
5 Clostridium Difficile Immunoassays Breakdown Data by Application
5.1 Global Clostridium Difficile Immunoassays Historic Market Size by Application (2018-2023)
5.2 Global Clostridium Difficile Immunoassays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clostridium Difficile Immunoassays Market Size (2018-2029)
6.2 North America Clostridium Difficile Immunoassays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clostridium Difficile Immunoassays Market Size by Country (2018-2023)
6.4 North America Clostridium Difficile Immunoassays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clostridium Difficile Immunoassays Market Size (2018-2029)
7.2 Europe Clostridium Difficile Immunoassays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clostridium Difficile Immunoassays Market Size by Country (2018-2023)
7.4 Europe Clostridium Difficile Immunoassays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clostridium Difficile Immunoassays Market Size (2018-2029)
8.2 Asia-Pacific Clostridium Difficile Immunoassays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clostridium Difficile Immunoassays Market Size by Region (2018-2023)
8.4 Asia-Pacific Clostridium Difficile Immunoassays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clostridium Difficile Immunoassays Market Size (2018-2029)
9.2 Latin America Clostridium Difficile Immunoassays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clostridium Difficile Immunoassays Market Size by Country (2018-2023)
9.4 Latin America Clostridium Difficile Immunoassays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clostridium Difficile Immunoassays Market Size (2018-2029)
10.2 Middle East & Africa Clostridium Difficile Immunoassays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clostridium Difficile Immunoassays Market Size by Country (2018-2023)
10.4 Middle East & Africa Clostridium Difficile Immunoassays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Inc.
11.1.1 Hologic Inc. Company Detail
11.1.2 Hologic Inc. Business Overview
11.1.3 Hologic Inc. Clostridium Difficile Immunoassays Introduction
11.1.4 Hologic Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.1.5 Hologic Inc. Recent Development
11.2 TECHLAB, Inc.
11.2.1 TECHLAB, Inc. Company Detail
11.2.2 TECHLAB, Inc. Business Overview
11.2.3 TECHLAB, Inc. Clostridium Difficile Immunoassays Introduction
11.2.4 TECHLAB, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.2.5 TECHLAB, Inc. Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Detail
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Clostridium Difficile Immunoassays Introduction
11.3.4 Roche AG Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.3.5 Roche AG Recent Development
11.4 Merck & Co.
11.4.1 Merck & Co. Company Detail
11.4.2 Merck & Co. Business Overview
11.4.3 Merck & Co. Clostridium Difficile Immunoassays Introduction
11.4.4 Merck & Co. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.4.5 Merck & Co. Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Detail
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Clostridium Difficile Immunoassays Introduction
11.5.4 Pfizer, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.5.5 Pfizer, Inc. Recent Development
11.6 Actelion Pharmaceuticals
11.6.1 Actelion Pharmaceuticals Company Detail
11.6.2 Actelion Pharmaceuticals Business Overview
11.6.3 Actelion Pharmaceuticals Clostridium Difficile Immunoassays Introduction
11.6.4 Actelion Pharmaceuticals Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.6.5 Actelion Pharmaceuticals Recent Development
11.7 Thermo Fisher Scientific Inc.
11.7.1 Thermo Fisher Scientific Inc. Company Detail
11.7.2 Thermo Fisher Scientific Inc. Business Overview
11.7.3 Thermo Fisher Scientific Inc. Clostridium Difficile Immunoassays Introduction
11.7.4 Thermo Fisher Scientific Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.7.5 Thermo Fisher Scientific Inc. Recent Development
11.8 Alere, Inc.
11.8.1 Alere, Inc. Company Detail
11.8.2 Alere, Inc. Business Overview
11.8.3 Alere, Inc. Clostridium Difficile Immunoassays Introduction
11.8.4 Alere, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.8.5 Alere, Inc. Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Detail
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Clostridium Difficile Immunoassays Introduction
11.9.4 Trinity Biotech Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.9.5 Trinity Biotech Recent Development
11.10 Baxter International Inc.
11.10.1 Baxter International Inc. Company Detail
11.10.2 Baxter International Inc. Business Overview
11.10.3 Baxter International Inc. Clostridium Difficile Immunoassays Introduction
11.10.4 Baxter International Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.10.5 Baxter International Inc. Recent Development
11.11 Sanofi SA
11.11.1 Sanofi SA Company Detail
11.11.2 Sanofi SA Business Overview
11.11.3 Sanofi SA Clostridium Difficile Immunoassays Introduction
11.11.4 Sanofi SA Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.11.5 Sanofi SA Recent Development
11.12 Summit Therapeutics
11.12.1 Summit Therapeutics Company Detail
11.12.2 Summit Therapeutics Business Overview
11.12.3 Summit Therapeutics Clostridium Difficile Immunoassays Introduction
11.12.4 Summit Therapeutics Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.12.5 Summit Therapeutics Recent Development
11.13 AstraZeneca Plc.
11.13.1 AstraZeneca Plc. Company Detail
11.13.2 AstraZeneca Plc. Business Overview
11.13.3 AstraZeneca Plc. Clostridium Difficile Immunoassays Introduction
11.13.4 AstraZeneca Plc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.13.5 AstraZeneca Plc. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Detail
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Clostridium Difficile Immunoassays Introduction
11.14.4 Novartis AG Revenue in Clostridium Difficile Immunoassays Business (2018-2023)
11.14.5 Novartis AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Clostridium Difficile Immunoassays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Common antigen (common enzyme or GDH) Test
Table 3. Key Players of Toxigenic Anaerobic Culture Test
Table 4. Key Players of Tissue Cytotoxin Neutralization Assay
Table 5. Key Players of Toxins A and B (EIA)
Table 6. Global Clostridium Difficile Immunoassays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Clostridium Difficile Immunoassays Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Clostridium Difficile Immunoassays Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Clostridium Difficile Immunoassays Market Share by Region (2018-2023)
Table 10. Global Clostridium Difficile Immunoassays Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Clostridium Difficile Immunoassays Market Share by Region (2024-2029)
Table 12. Clostridium Difficile Immunoassays Market Trends
Table 13. Clostridium Difficile Immunoassays Market Drivers
Table 14. Clostridium Difficile Immunoassays Market Challenges
Table 15. Clostridium Difficile Immunoassays Market Restraints
Table 16. Global Clostridium Difficile Immunoassays Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Clostridium Difficile Immunoassays Market Share by Players (2018-2023)
Table 18. Global Top Clostridium Difficile Immunoassays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridium Difficile Immunoassays as of 2022)
Table 19. Ranking of Global Top Clostridium Difficile Immunoassays Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Clostridium Difficile Immunoassays Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Clostridium Difficile Immunoassays Product Solution and Service
Table 23. Date of Enter into Clostridium Difficile Immunoassays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Clostridium Difficile Immunoassays Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Clostridium Difficile Immunoassays Revenue Market Share by Type (2018-2023)
Table 27. Global Clostridium Difficile Immunoassays Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Clostridium Difficile Immunoassays Revenue Market Share by Type (2024-2029)
Table 29. Global Clostridium Difficile Immunoassays Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Clostridium Difficile Immunoassays Revenue Market Share by Application (2018-2023)
Table 31. Global Clostridium Difficile Immunoassays Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Clostridium Difficile Immunoassays Revenue Market Share by Application (2024-2029)
Table 33. North America Clostridium Difficile Immunoassays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Clostridium Difficile Immunoassays Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Clostridium Difficile Immunoassays Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Clostridium Difficile Immunoassays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Clostridium Difficile Immunoassays Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Clostridium Difficile Immunoassays Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Clostridium Difficile Immunoassays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Clostridium Difficile Immunoassays Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Clostridium Difficile Immunoassays Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Clostridium Difficile Immunoassays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Clostridium Difficile Immunoassays Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Clostridium Difficile Immunoassays Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Clostridium Difficile Immunoassays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Clostridium Difficile Immunoassays Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Clostridium Difficile Immunoassays Market Size by Country (2024-2029) & (US$ Million)
Table 48. Hologic Inc. Company Detail
Table 49. Hologic Inc. Business Overview
Table 50. Hologic Inc. Clostridium Difficile Immunoassays Product
Table 51. Hologic Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 52. Hologic Inc. Recent Development
Table 53. TECHLAB, Inc. Company Detail
Table 54. TECHLAB, Inc. Business Overview
Table 55. TECHLAB, Inc. Clostridium Difficile Immunoassays Product
Table 56. TECHLAB, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 57. TECHLAB, Inc. Recent Development
Table 58. Roche AG Company Detail
Table 59. Roche AG Business Overview
Table 60. Roche AG Clostridium Difficile Immunoassays Product
Table 61. Roche AG Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 62. Roche AG Recent Development
Table 63. Merck & Co. Company Detail
Table 64. Merck & Co. Business Overview
Table 65. Merck & Co. Clostridium Difficile Immunoassays Product
Table 66. Merck & Co. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 67. Merck & Co. Recent Development
Table 68. Pfizer, Inc. Company Detail
Table 69. Pfizer, Inc. Business Overview
Table 70. Pfizer, Inc. Clostridium Difficile Immunoassays Product
Table 71. Pfizer, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 72. Pfizer, Inc. Recent Development
Table 73. Actelion Pharmaceuticals Company Detail
Table 74. Actelion Pharmaceuticals Business Overview
Table 75. Actelion Pharmaceuticals Clostridium Difficile Immunoassays Product
Table 76. Actelion Pharmaceuticals Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 77. Actelion Pharmaceuticals Recent Development
Table 78. Thermo Fisher Scientific Inc. Company Detail
Table 79. Thermo Fisher Scientific Inc. Business Overview
Table 80. Thermo Fisher Scientific Inc. Clostridium Difficile Immunoassays Product
Table 81. Thermo Fisher Scientific Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific Inc. Recent Development
Table 83. Alere, Inc. Company Detail
Table 84. Alere, Inc. Business Overview
Table 85. Alere, Inc. Clostridium Difficile Immunoassays Product
Table 86. Alere, Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 87. Alere, Inc. Recent Development
Table 88. Trinity Biotech Company Detail
Table 89. Trinity Biotech Business Overview
Table 90. Trinity Biotech Clostridium Difficile Immunoassays Product
Table 91. Trinity Biotech Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 92. Trinity Biotech Recent Development
Table 93. Baxter International Inc. Company Detail
Table 94. Baxter International Inc. Business Overview
Table 95. Baxter International Inc. Clostridium Difficile Immunoassays Product
Table 96. Baxter International Inc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 97. Baxter International Inc. Recent Development
Table 98. Sanofi SA Company Detail
Table 99. Sanofi SA Business Overview
Table 100. Sanofi SA Clostridium Difficile Immunoassays Product
Table 101. Sanofi SA Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 102. Sanofi SA Recent Development
Table 103. Summit Therapeutics Company Detail
Table 104. Summit Therapeutics Business Overview
Table 105. Summit Therapeutics Clostridium Difficile Immunoassays Product
Table 106. Summit Therapeutics Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 107. Summit Therapeutics Recent Development
Table 108. AstraZeneca Plc. Company Detail
Table 109. AstraZeneca Plc. Business Overview
Table 110. AstraZeneca Plc. Clostridium Difficile Immunoassays Product
Table 111. AstraZeneca Plc. Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 112. AstraZeneca Plc. Recent Development
Table 113. Novartis AG Company Detail
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Clostridium Difficile Immunoassays Product
Table 116. Novartis AG Revenue in Clostridium Difficile Immunoassays Business (2018-2023) & (US$ Million)
Table 117. Novartis AG Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clostridium Difficile Immunoassays Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Clostridium Difficile Immunoassays Market Share by Type: 2022 VS 2029
Figure 3. Common antigen (common enzyme or GDH) Test Features
Figure 4. Toxigenic Anaerobic Culture Test Features
Figure 5. Tissue Cytotoxin Neutralization Assay Features
Figure 6. Toxins A and B (EIA) Features
Figure 7. Global Clostridium Difficile Immunoassays Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Clostridium Difficile Immunoassays Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Clostridium Difficile Immunoassays Report Years Considered
Figure 13. Global Clostridium Difficile Immunoassays Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Clostridium Difficile Immunoassays Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Clostridium Difficile Immunoassays Market Share by Region: 2022 VS 2029
Figure 16. Global Clostridium Difficile Immunoassays Market Share by Players in 2022
Figure 17. Global Top Clostridium Difficile Immunoassays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridium Difficile Immunoassays as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Clostridium Difficile Immunoassays Revenue in 2022
Figure 19. North America Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Clostridium Difficile Immunoassays Market Share by Country (2018-2029)
Figure 21. United States Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Clostridium Difficile Immunoassays Market Share by Country (2018-2029)
Figure 25. Germany Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Clostridium Difficile Immunoassays Market Share by Region (2018-2029)
Figure 33. China Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Clostridium Difficile Immunoassays Market Share by Country (2018-2029)
Figure 41. Mexico Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Clostridium Difficile Immunoassays Market Share by Country (2018-2029)
Figure 45. Turkey Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Clostridium Difficile Immunoassays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Hologic Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 48. TECHLAB, Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 49. Roche AG Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 50. Merck & Co. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 51. Pfizer, Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 52. Actelion Pharmaceuticals Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 53. Thermo Fisher Scientific Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 54. Alere, Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 55. Trinity Biotech Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 56. Baxter International Inc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 57. Sanofi SA Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 58. Summit Therapeutics Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 59. AstraZeneca Plc. Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Clostridium Difficile Immunoassays Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 細胞培養プロセス開発の世界市場2023年：上流工程開発、下流工程開発
  • KNX認定製品の世界市場2023年：エネルギー管理、HVACシステム、ブラインド＆シャッター、メーター、リモコン、監視システム、火災＆煙検出、白物家電、照明
  • プライベートセキュリティサービスの世界市場2023年：警備、警報監視、装甲輸送、私立探偵、その他
  • 血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他
  • アイサプリメントの世界市場2023年：ルテイン、ブルーベリー、グレープシード
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7444 )"クロストリジウムディフィシルイムノアッセイの世界市場2023年：共通抗原（共通酵素/GDH）試験、Toxigenic Anaerobic Culture Test、Tissue Cytotoxin Neutralization Assay、Toxins A and B (EIA)" (英文：Global Clostridium Difficile Immunoassays Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。